DUBLIN--(BUSINESS WIRE)--The "Pompe Disease - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
'Pompe Disease - Pipeline Insight, 2018' report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pompe Disease development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
Pipeline Products covered across the following Developmental Stages:
- Clinical
- Non-clinical
- Inactive: Discontinued and/or Dormant
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.
The report assesses the active Pompe Disease pipeline products by developmental stage, product type, molecule type, and administration route.
Key Topics Covered:
1. Report Introduction
2. Pompe Disease Overview
3. Pipeline Therapeutics
- An Overview of Pipeline Products for Pompe Disease
4. Comparative Analysis
5. Products in Clinical Stage
- Product Description
- Research and Development
- Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
- Product Description
- Research and Development
- Product Development Activities
7. Therapeutic Assessment
- Assessment by Route of Administration
- Assessment by Stage and Route of Administration
- Assessment by Molecule Type
- Assessment by Stage and Molecule Type
8. Inactive Products
- Product Description
- Research and Development
- Product Development Activities
Companies Mentioned
- Amicus Therapeutics Inc
- Audentes Therapeutics Inc
- EpiVax Inc
- Etubics Corp
- Genzyme Corp
- Greenovation Biotech GmbH
- Huons Co Ltd
- JCR Pharmaceuticals Co Ltd
- Oxyrane Belgium NV
- Pharming Group NV
- Sarepta Therapeutics Inc
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/hhmjv9/global_pompe?w=4
